KESTRA MEDICAL TECHNOLOGIES LTD (KMTS)
Health Care · Wearable cardiac devices / cardiac monitoring · NASDAQ
Kestra makes wearable defibrillators (ASSURE WCD) that protect cardiac patients from sudden death during recovery periods.
What KESTRA MEDICAL TECHNOLOGIES LTD does
Kestra Medical Technologies develops and commercializes the ASSURE wearable cardioverter-defibrillator (WCD) and associated products as part of its Cardiac Recovery System platform, which is designed to protect patients at risk of sudden cardiac death. The company is focused on expanding the commercialization of its WCD device across multiple markets and regulatory jurisdictions.
Themes: ["cardiac arrhythmia / sudden cardiac death","wearable medical devices","cardiac care"]
Fundamentals
- Price$26.69 as of 2026-07-09 close
- Market cap$1.6B as of 2026-07-10
- 1-year return+69.8% as of 2026-07-09 close
- Net margin-173.0% as of 2026-07-10
- Gross margin+48.8% as of 2026-07-10
- ROE-68.8% as of 2026-07-10
- Debt / equity0.15 as of 2026-07-10
- Revenue growth (YoY)+59.1% as of 2026-07-10
- Beta1.55 as of 2026-07-10
Key risks (from latest filing)
["Dependency on regulatory approvals and market acceptance of ASSURE WCD to drive revenue growth and commercialization expansion","Reimbursement availability and insurance coverage challenges for wearable defibrillator products","Manufacturing scalability and supply chain management for component sourcing and inventory distribution"]
Competitors & peers
- Zoll Medical Corporation
- Philips Healthcare
- Medtronic
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.